Prostatic Neoplasms: all 6,484 studies
Page 45 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.
- Prospective Evaluation of 68Ga-PSMA PET-CT for Recurrence Detection of Prostate Cancer and Its Impact on Patient ManagementWithdrawnNCT02810886Phase 2
- 18F-FMAU PET/CT in Diagnosing and Characterizing Prostate CancerTerminatedNCT02809690Phase 1
- Digital Application Usage for Adherence of Patients Undergoing Robotic Assisted Radical Prostatectomy Following Oncological and Postoperative Functional OutcomesStatus unknownNCT02809495
- Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate CancerActive, not recruitingNCT02807805Phase 2
- Solifenacin Succinate for Treatment of Urinary Toxicity Occurring During Radiotherapy of Prostatic CancerTerminatedNCT02805452Phase 3
- Longitudinal Evaluation of Intestinal, Haematological and Urinary Toxicity From Pelvic Irradiation for Prostate CancerActive, not recruitingNCT02803086
- Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate CancerActive, not recruitingNCT02799706Phase 3
- MRI Versus PSA in Prostate Cancer ScreeningStatus unknownNCT02799303Not applicable
- Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate CancerCompletedNCT02796898Phase 1/2
- Correlation Between SUV on 68Ga-HBED-CC-PSMA and Gleason Score in Prostate CancerCompletedNCT02796807Phase 2
- Correlation Between SUV on 18F-Fluorocholine PET/CT and Gleason Score in Prostate CancerCompletedNCT02793882
- Docetaxel Followed by Provenge in Metastatic Prostate CancerWithdrawnNCT02793765Phase 2
- Provenge Followed by Docetaxel in Castration-Resistant Prostate CancerWithdrawnNCT02793219Phase 2
- Deformable Registration of Multi-parametric MRI to Intra-operative Transrectal Ultrasound for Prostate BrachytherapyStatus unknownNCT02790216
- Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate CancerCompletedNCT02789878Phase 2
- STHLM3-MR: Comparing Standard With Targeted Prostate BiopsiesCompletedNCT02788825Not applicable
- Incidence of Second Primary Malignancies in Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the USCompletedNCT02788409
- PROSABI: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Abiraterone Acetate.Status unknownNCT02787837
- Addressing Prostate Cancer Information Disparities With eHealth TechnologyCompletedNCT02787434Not applicable
- Detection and Localization of Carcinoma Using High Resolution Transrectal Imaging - Proof of Concept StudyCompletedNCT02786459Not applicable
- Impact of Geriatrician Interventions on Chemotherapy Delivery in Vulnerable Elderly Oncology PatientsCompletedNCT02785887Not applicable
- Assessment of Bone Loss in Men Receiving Treatment for Prostate CancerStatus unknownNCT02785627
- Cost Efficacy Evaluation of Robot Assisted Radical ProstatectomyCompletedNCT02784314Not applicable
- Reducing Dexamethasone Around Docetaxel InfusionCompletedNCT02776436Phase 1
- ClariCore™ Biopsy System in Patients Undergoing Radical Retropubic ProstatectomyStatus unknownNCT02773940Not applicable
- Analysis of Cell-free DNA (cfDNA) in Men With Elevated PSA LevelsTerminatedNCT02771769
- Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)Active, not recruitingNCT02768363Phase 2
- sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney CancerTerminatedNCT02767921Phase 1
- Preference-based Comparative Study on Definitive Radiotherapy of Prostate Cancer With ProtonsCompletedNCT02766686Not applicable
- Pivotal Study of MRI-guided Transurethral Ultrasound Ablation in Patients With Localized Prostate CancerActive, not recruitingNCT02766543Not applicable
- Does End-fire Technique Increase Detection Rate of Prostate Cancer at First Re-biopsy Compared to Side-fire Technique?CompletedNCT02761135
- Can Dietary Phytoestrogens Slow Down Prostate Tumor Proliferation?Status unknownNCT02759380Not applicable
- Efficiency Study of Aspirin to Prevent the Occurrence of Prostate CancerStatus unknownNCT02757365Phase 4
- Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate CancerTerminatedNCT02749825Phase 4
- Evaluation of PSA Blood Levels Prior to and After Digital Rectal ExaminationStatus unknownNCT02747563Phase 1
- A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate CancerCompletedNCT02747342Phase 1
- 68Ga-NOTA-BBN-RGD PET/CT in Prostate Cancer PatientsStatus unknownNCT02747290Early Phase 1
- Evaluating the Impact of Prostate Only Versus Pelvic Radiation for N+ Prostate Cancer.TerminatedNCT02745587Phase 3
- Advanced Magnetic Resonance Imaging (MRI) in Men With Suspected Prostate CancerCompletedNCT02745496Not applicable
- Safety and Activity Study of PSCA-Targeted CAR-T Cells (BPX-601) in Subjects With Selected Advanced Solid TumorsTerminatedNCT02744287Phase 1
- Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)Status unknownNCT02742675Phase 2
- Validation of the Prostate Cancer Assay - Beta+PivotalWithdrawnNCT02742259
- A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid MalignanciesCompletedNCT02740985Phase 1
- Carbon Ion Radiotherapy for the Treatment of Localized Prostate CancerStatus unknownNCT02739659Not applicable
- Changes of Immunologic Function in Patients of Prostate Cancer Induced After Cryoablation.Status unknownNCT02739048
- PROMOTE: Identifying Predictive Markers of Response for Genitourinary CancerActive, not recruitingNCT02735252Not applicable
- Validation of Radioisotope Guided Lymphadenectomy for Loco-regional Staging in Patients With Intermediate or High-risk Prostate CancerCompletedNCT02732392Not applicable
- Pharmacokinetic Food-effect Study of Abiraterone Acetate (AA) in Castration Resistant Prostate CancerCompletedNCT02730975Phase 1
- INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4)Active, not recruitingNCT02730338Not applicable
- Treatment Patterns in Metastatic Prostate CancerCompletedNCT02729103
- A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate CancerCompletedNCT02726009Phase 4
- Nanocurcumin for Prostate Cancer Patients Undergoing Radiotherapy (RT)Status unknownNCT02724618Phase 2
- Validation Study on the Impact of Decipher® Testing - VANDAAM StudyActive, not recruitingNCT02723734
- Expression of Tumor Markers in Circulating Tumor Cells of Metastatic Hormone-sensitive Prostate CancerStatus unknownNCT02723526
- Cardiac MRI in Measuring the Impact of Anti-androgen Treatment on Cardiac Function in Patients With Prostate CancerActive, not recruitingNCT02722525Not applicable
- Serial mpMRI (Multi Parametric Magnetic Resonance Imaging) Scanning in Prostate Cancer After Androgen Deprivation Therapy and RadioTherapyStatus unknownNCT02721784Phase 1/2
- 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone MetastasesCompletedNCT02721433Phase 4
- Evaluation of Safety and Efficacy of Estetrol in Healthy MenCompletedNCT02718378Phase 1
- Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid TumorsActive, not recruitingNCT02717156Phase 2
- C-Acetate PET/CT Imaging to Evaluate Treatment Changes in Prostate CancerCompletedNCT02715583Early Phase 1
- Cancer Diagnosis by Multiparametric UltraSound of the ProstateStatus unknownNCT02712684
- Fasting and Nutritional Therapy in Patients With Advanced Metastatic Prostate CancerCompletedNCT02710721Not applicable
- A Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT02705469Phase 1
- Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE)CompletedNCT02704832Not applicable
- Quality of Life and Supportive Care Preferences Following Radiation Therapy in Prostate Cancer SurvivorsCompletedNCT02704377Not applicable
- Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate CancerActive, not recruitingNCT02703623Phase 2
- Second Primary Cancers in Patients With Castration Resistant Prostate CancerCompletedNCT02702908
- Clinical Validation of a Urinary Exosome Gene Signature in Men Presenting for Suspicion of Prostate CancerCompletedNCT02702856
- True NTH Sexual Recovery Intervention for Prostate Cancer Survivors and Their PartnersCompletedNCT02702453Not applicable
- Prospective Evaluation of 68-Ga-prostate Specific Membrane Antigen (PSMA)-Positron Emission Tomograph (PET) and Early Prostatic Specific Antigen (PSA) Kinetics During Salvage Radiotherapy for Personalizing the Management of Men With Relapse of Prostate Cancer After Radical ProstatectomyCompletedNCT02699424Not applicable
- Neoadjuvant J591 Treatment for Prostate CancerCompletedNCT02693860Phase 1
- Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer PatientsCompletedNCT02692976Phase 2
- Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate CancerActive, not recruitingNCT02692105Phase 3
- A Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer PatientsStatus unknownNCT02691975Phase 1/2
- Integrated 18F-labelled PSMA ProjectStatus unknownNCT02691169Early Phase 1
- CombIning advaNces in imagiNg With biOmarkers for improVed Diagnosis of Aggressive prosTate cancErCompletedNCT02689271
- Open Anterograde Radical Prostatectomy Compared to Open Retrograde TechniqueCompletedNCT02687308Not applicable
- Management of Castration-Resistant Prostate Cancer with OligometastasesActive, not recruitingNCT02685397Phase 2/3
- MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate TissueCompletedNCT02680535Not applicable
- Momentum Project Heidelberg - Dealing Actively With a Cancerous DiseaseCompletedNCT02678832
- Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer PatientsWithdrawnNCT02678520Phase 2
- MR-targeted vs. Random TRUS-guided Prostate BiopsyStatus unknownNCT02678481Not applicable
- Imaging Biomarkers to Validate Response in Enzalutamide-Treated mCRPCCompletedNCT02677376
- Determinants of Quality Of Life in AGEd Cancer PatientsStatus unknownNCT02672657
- Long-Term Specified Drug Use-Results Survey for Xtandi CapsuleCompletedNCT02669771
- A Study to Determine Enzalutamide Long-term Safety and Efficacy After Anti-androgen Therapy for CRPCCompletedNCT02669147
- Adjuvant Radiation Therapy vs. Watchful Waiting Following Radical Prostatectomy in High Risk Prostate CancerStatus unknownNCT02668718Phase 3
- Engaging Newly Diagnosed Men About Cancer Treatment OptionsCompletedNCT02668276Not applicable
- Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) TolerabilityCompletedNCT02663193
- Evaluation of Focal Treatments of Localized Prostate Cancers With High Intensity Focused Ultrasound Using the Focal One® DeviceCompletedNCT02662673Not applicable
- PET/MRI in Patients With Suspected Prostate CancerCompletedNCT02659527Phase 3
- Cancer DNA Detection in Blood and UrineCompletedNCT02657863
- Abiraterone-Rechallenge Study for CRPC PatientsTerminatedNCT02656615Phase 2
- Radium 223 Following Intermittent ADTWithdrawnNCT02656563Phase 2
- Dose Escalating Study of Foxy-5 in Breast-, Colon- or Prostate Cancer PatientsCompletedNCT02655952Phase 1
- Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced CancersCompletedNCT02655822Phase 1
- Safety and Tolerability Clinical Trial of Different Doses of the Immunotherapeutic Drug Mobilan (M-VM3) and Placebo in Patients With Prostate CancerCompletedNCT02654938Phase 1
- SBRT for Organ Confined Prostate CancerCompletedNCT02653248Phase 1
- Quality of Life After Permanent Interstitial Iodine Seed Prostate BrachytherapyCompletedNCT02652000
- Transperineal, MRI-guided, Prostate BiopsyCompletedNCT02651948Phase 4